Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Interferon beta-1b MeSH Descriptor Data 2026


MeSH Heading
Interferon beta-1b
Tree Number(s)
D12.644.276.374.440.890.275.750
D12.776.467.374.440.890.275.750
D23.529.374.440.890.275.750
Unique ID
D000068576
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068576
Scope Note
A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
Entry Term(s)
Beta-IFN-1b
Beta-Seron
Betaferon
Betaseron
Extavia
IFN-Beta Ser
Interferon Beta, Ser(17)
Interferon Beta, Serine(17)
Interferon beta 1b
Ser(17) IFN-beta
Serine(17) Interferon Beta
Pharm Action
Adjuvants, Immunologic
Registry Numbers
145155-23-3
0
Public MeSH Note
2016; INTERFERON BETA-1B was previously indexed under INTERFERON BETA, 1991-2015; RECOMBINANT PROTEINS, 1988-1991; and under INTERFERON TYPE I, 1985-1988
History Note
2016 (1985)
Date Introduced
2016/01/01
Last Updated
2017/12/14
Interferon beta-1b Preferred
Betaseron Narrower
Extavia Narrower
Betaferon Narrower
page delivered in 0.126s